Denmark· DK-28101346488
Benaliv
A levocabastine product containing levocabastinhydrochlorid, registered in Denmark by McNeil Denmark ApS. The same ATC class is registered in 9 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Levocabastine is registered in 9 of 19 countries.
Countries holding a registration under ATC S01GX02 (levocabastine), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 6 of them publish a price we can compare per daily dose
Levocabastine · ATC S01GX02
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Levocabastinhydrochlorid
- Manufacturer
- McNeil Denmark ApS
- Country
- Denmark (DK)
- ATC code
- S01GX02
- ATC class
- Levocabastine
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28101346488
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under S01GX02
Levocabastine, as other registers publish it.
- NetherlandsLivocab 0,5 mg/ml oogdruppels, suspensieKenvue Netherlands B.V.
- NorwayLivostinMcNeil Sweden AB
- FinlandLivostinMcNeil / JNTL Consumer Health (Finland) Oy
- FinlandLivostinParanova Oy
- FinlandLivostinOrion Corporation Orion Pharma
- IcelandLivostinMcNeil Sweden AB
- CzechiaLIVOSTINMcNeil Healthcare (Ireland) Limited, Dublin
- BelgiumLivostin 0.5 mg/mlOrifarm
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/becd9992-ae7a-4538-9770-9af4e207dde3 GET /v1/drugs/becd9992-ae7a-4538-9770-9af4e207dde3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "øjendråber, suspension",
"source": "dkma",
"strength": "0,5 mg/ml",
"auth_role": "DKMA",
"dk_drugid": "28101346488",
"substance": "Levocabastinhydrochlorid",
"auth_procedure": "National",
"in_medicinpriser": true,
"registration_date_serial": "33273"
}See everything about levocabastine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.